Julie Blasingim, MBA, has over 15 years of regulatory, operational, and compliance experience in the human research protection field. She currently serves as Vice President of Corporate Quality Assurance, Process Improvement, and Training for Advarra. Blasingim is uniquely experienced to have a broad understanding of the entire IRB business, having served in a number of roles responsible for providing leadership and oversight within the organization, ensuring compliance with policies and regulatory requirements, and providing timely and quality review services to clients.
Before Advarra, Blasingim played a key role in the development and expansion of several service lines at Schulman IRB, including clinical pharmacology/Phase I, institutional review and support, Central Oncology Review (COR) IRB panel, and eConsent. She has also served as IRB chair and led and organized the application process for AAHRPP accreditation, FDA audits, project management, change management, process improvement, and other strategic initiatives. Blasingim has also been a key member of integration teams for three IRB-related mergers and acquisitions.
Blasingim holds a bachelor’s degree in education and a master’s degree in business administration specializing in leadership and has maintained her Certified IRB Professional (CIP) certificate for 10 years. She provides training and educational sessions within the company, to researchers, and for professional learning groups and conferences across the research community and has also authored two CITI training modules.